✦ LIBER ✦

Prospects and prejudices of human papillomavirus vaccines in India

✍ Scribed by Bhudev C. Das; Showket Hussain; Vilas Nasare; Mausumi Bharadwaj

Book ID: 116960475
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 621 KB
Volume: 26
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2008.03.056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Human papillomavirus vaccine trials in I

Human papillomavirus vaccine trials in India

✍ Amit Sengupta; Anjali Shenoi; NB Sarojini; Y Madhavi 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 85 KB

Human papillomavirus vaccines

✍ Professor Alison N. Fiander 📂 Article 📅 2004 🏛 Royal College of Obstetricians and Gynaecologists ⚖ 143 KB

Human papillomavirus infection among you

Human papillomavirus infection among young adolescents in India: Impact of vaccination

✍ Showket Hussain; Mausumi Bharadwaj; Vilas Nasare; Malasha Kumari; Shashi Sharma; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

## Abstract High‐risk human papillomaviruses (HR‐HPVs) are the causative agents of cervical cancer and prophylactic HPV vaccination has been recommended for adolescents but no data are available on the prevalence of HPV infection among adolescents in India. Self‐collected midstream urine samples fr

Human Papillomavirus (HPV) Infection in

Human Papillomavirus (HPV) Infection in Southern Africa: Prevalence, Immunity, and Vaccine Prospects

✍ Anna-Lise Williamson; Dianne Marais; Jo-Ann Passmore; Ed Rybicki 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Update on human papillomavirus vaccines

✍ Alison Fiander 📂 Article 📅 2006 🏛 Royal College of Obstetricians and Gynaecologists ⚖ 64 KB

Integration of human papillomavirus vacc

Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing

✍ Schiffman, Mark 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB

There is justifiable excitement about the recent introduction of prophylactic vaccines against human papillomavirus (HPV) types 16 (HPV-16) and HPV-18. Preventing these infections theoretically could avert approximately 70% of cervical cancer cases worldwide. In the U.S., numerous influential advoca